Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
search
Subscribe
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
Subscribe
FREE
Edition
European
US
Dermatology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Melanoma Quality of Life During and After Immunotherapy
October 2025
Melanoma quality of life differs during and after immunotherapy, with fatigue, skin issues, and sexual dysfunction.
Read more
17 Jul 2025
More Infants Treated for Hemangiomas Post-Beta-Blocker Era
The use of beta-blockers has dramatically changed the management of infantile hemangiomas, with a significant increase in active treatment decisions at tertiary referral centers, according to a new retrospective cohort study.
16 Jul 2025
New Mortality Risk Model for Severe Drug Reaction
A new international study has developed and validated prognostic models using novel inflammatory markers to predict in-hospital mortality in patients with drug reaction with eosinophilia and systemic symptoms (DRESS), a rare but life-threatening hypersensitivity reaction.
11 Jul 2025
What Your Skin Health Says About Gluten Sensitivity
Gluten-related skin conditions may extend well beyond the classic dermatitis herpetiformis, according to a new overview of gluten-induced dermatoses that highlights diagnostic and therapeutic pathways for clinicians.
11 Jul 2025
Climate Change Threatens Women’s Health
Climate change is severely affecting the physical and psychological health of reproductive-age women living in Bangladesh’s coastal communities, according to a new study.
11 Jul 2025
Sunlight Sensitivity Disorder Tied to Squamous Cell Carcinoma
Skin cancer risk remains high in patients with xeroderma pigmentosum, including rare long-term survivors, according to a newly reported case of squamous cell carcinoma (SCC) in a 55-year-old woman with the condition.
9 Jul 2025
Primary Care Physicians Pivotal in Eosinophilic Disease Diagnosis
Primary care physicians are pivotal in the early recognition and referral of rare eosinophilic diseases, such as hypereosinophilic syndrome (HES) and eosinophilic granulomatosis with polyangiitis (EGPA), which remain underdiagnosed despite their serious multisystem impact.
6 Jul 2025
Which Specialists Excise BCCs Most Effectively?
A nationwide study of basal cell carcinoma (BCC) excisions in Denmark found that hospital-based specialists have significantly lower odds of incomplete removal than their practice-based peers, raising important questions about treatment setting and provider expertise.
2 Jul 2025
Autoimmune Skin Diseases Linked to Better Cancer Survival Outcomes
Patients with autoimmune skin diseases (ASDs) may have improved survival following cancer treatment, according to a large population-based study, suggesting a possible immunologic advantage in oncologic outcomes.
Loading posts...
« Previous
1
…
3
4
5
6
7
…
17
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View